Extraskeletal Myxoid Chondrosarcoma in a 19-Year-Old Female: A Case Report Highlighting Diagnostic Challenges and Aggressive Clinical Course
Main Article Content
Abstract
Extraskeletal Myxoid Chondrosarcoma (EMC) is a rare soft tissue sarcoma, traditionally characterized by an indolent clinical course and occurrence in the fifth or sixth decades of life. Presentation in adolescents is exceptionally rare and often poses significant diagnostic challenges due to its benign-mimicking radiological appearance. A 19-year-old female presented with a painless subcutaneous nodule in the right scapular region. Initial ultrasound (US) misinterpreted the lesion as a sebaceous cyst due to the hypoechoic nature of the myxoid matrix, leading to a one-year diagnostic delay. Following rapid growth and subsequent biopsy, the patient underwent a wide R0 surgical resection. Histopathological analysis revealed high-grade features, including a mitotic index >20/10 HPF and 20% necrosis, within a 20.0 cm surgical specimen. Despite complete resection, the patient developed widespread pulmonary and lymph node metastases within months. Due to the characteristic chemoresistance of EMC, palliative care was initiated, and the patient passed away five months after the definitive diagnosis. This case challenges the traditional "indolent" classification of EMC. The high mitotic activity and extensive necrosis in this young patient represent a high-grade outlier compared to classic cohorts. The diagnostic delay highlights the need to include rare sarcomas in the differential diagnosis of subcutaneous nodules, regardless of age or benign initial imaging. EMC in young patients can exhibit a highly aggressive phenotype with rapid systemic progression. Early diagnostic suspicion and a multidisciplinary approach are crucial for managing this unpredictable and potentially fatal neoplasm.
Article Details

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their articles and grant the journal the right of first publication under the Creative Commons Attribution (CC BY) license, which allows others to share and adapt the work with proper attribution.
References
Oliveira AM, Sebo TJ, McGrory JE, Gaffey TA, Rock MG, Nascimento AG. Extraskeletal myxoid chondrosarcoma: a clinico-pathologic, immunohistochemical, and ploidy analysis of 23 cases. Mod Pathol. 2000;13(8):900-8. doi: 10.1038/modpathol.3880161.
Gama JM, et al. Extraskeletal myxoid chondrosarcoma metastasis to a Meckel's diverticulum adenocarcinoma. Rev Esp Patol. 2024. [Epub ahead of print].
WHO Classification of Tumours Editorial Board. Soft tissue and bone tumours. 5th ed. Lyon (France): International Agency for Research on Cancer; 2020. (WHO classification of tumours series, vol. 3).
Fisher C, et al. Diagnostic Pathology: Soft Tissue Tumors. Salt Lake City: Amirsys; 2011.
Goldblum JR, Folpe AL, Weiss SW. Enzinger and Weiss’s Soft Tissue Tumors. 6th ed. Philadelphia: Elsevier; 2014.
Meis-Kindblom JM, Bergh P, Gunterberg B, Kindblom LG. Extraskeletal myxoid chondrosarcoma: a reappraisal of its morphologic spectrum and prognostic factors based on 117 cases. Am J Surg Pathol. 1999;23(6):636-50. doi: 10.1097/00000478-199906000-00001.
Carnio N, Ribeiro HM, Guimarães WM, PM Filho. Condrossarcoma mixóide extraesquelético: fratura patológica secundária à neoplasia? Rev Patol Tocantins. 2023;10(1):[página se houver].
Zaki M, Laszewski P, Robinette N, et al. Unresectable Extraskeletal Myxoid Chondrosarcoma of the Neck: Early Tumor Response to Chemoradiotherapy. Cureus. 2015;7(12):e432. doi: 10.7759/cureus.432.
Kawaguchi S, et al. Extraskeletal myxoid chondrosarcoma: a multi-institutional study of 42 cases in Japan. Cancer. 2003;97(5):1285-92. doi: 10.1002/cncr.11162.
Dornelas BC, et al. Volumoso condrossarcoma mixoide extraesquelético abdominal: relato de caso. J Bras Patol Med Lab. 2019;55:[página].
Drilon AD, Popat S, Bhuchar G, et al. Extraskeletal myxoid chondrosarcoma: a retrospective review from 2 referral centers emphasizing long-term outcomes with surgery and chemotherapy. Cancer. 2008;113(12):3364-71. doi: 10.1002/cncr.23974.
Paioli A, Stacchiotti S, Campanacci D, et al. Extraskeletal Myxoid Chondrosarcoma with Molecularly Confirmed Diagnosis: A Multicenter Retrospective Study Within the Italian Sarcoma Group. Ann Surg Oncol. 2021;28(2):1142-1150. doi: 10.1245/s10434-020-08737-7.
Gilbert A, et al. Chondrosarcoma Resistance to Radiation Therapy: Origins and Potential Therapeutic Solutions. Cancers (Basel). 2023;15(7):1962. doi: 10.3390/cancers15071962.
Stacchiotti S, et al. Anthracycline-based chemotherapy in advanced extraskeletal myxoid chondrosarcoma: a retrospective study from the World Sarcoma Network. Ann Oncol. 2019;30(Suppl 5):v695-v696.